AU4916299A - Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates - Google Patents

Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates

Info

Publication number
AU4916299A
AU4916299A AU49162/99A AU4916299A AU4916299A AU 4916299 A AU4916299 A AU 4916299A AU 49162/99 A AU49162/99 A AU 49162/99A AU 4916299 A AU4916299 A AU 4916299A AU 4916299 A AU4916299 A AU 4916299A
Authority
AU
Australia
Prior art keywords
vertebrates
baculovirus
nucleic acids
nerve cells
vectors derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49162/99A
Inventor
Jacques Mallet
Chamsy Sarkis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9809457A external-priority patent/FR2781503B1/en
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU4916299A publication Critical patent/AU4916299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU49162/99A 1998-07-24 1999-07-23 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates Abandoned AU4916299A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9809457A FR2781503B1 (en) 1998-07-24 1998-07-24 NOVEL VECTORS DERIVED FROM BACULOVIRUS AND USE THEREOF FOR TRANSFERRING NUCLEIC ACIDS IN NERVOUS CELLS
FR9809457 1998-07-24
US12279299P 1999-03-04 1999-03-04
US60122792 1999-03-04
PCT/FR1999/001813 WO2000005394A1 (en) 1998-07-24 1999-07-23 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates

Publications (1)

Publication Number Publication Date
AU4916299A true AU4916299A (en) 2000-02-14

Family

ID=26234459

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49162/99A Abandoned AU4916299A (en) 1998-07-24 1999-07-23 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates

Country Status (4)

Country Link
EP (1) EP1100946A1 (en)
JP (1) JP2003527816A (en)
AU (1) AU4916299A (en)
WO (1) WO2000005394A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012997D0 (en) * 2000-05-26 2000-07-19 Eurogene Limited Gene delivery
WO2002014527A2 (en) * 2000-08-11 2002-02-21 Boyce Thompson Institute For Plant Research, Inc. Gp64-null baculoviruses pseudotyped with heterologous envelope proteins
WO2002096469A2 (en) * 2001-05-29 2002-12-05 Ark Therapeutics Ltd. Gene delivery via a baculovirus vector
US8034331B2 (en) * 2005-01-20 2011-10-11 Agency For Science, Technology And Research Method of delivery of nucleic acids to peripheral neurons
CN101033471B (en) * 2007-02-08 2011-06-08 四川大学 Colibacillus-lactic acid bacteria shuttle plasmid capable of expressing and excreting beta-galactosidase and its construction method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6338953B1 (en) * 1996-09-11 2002-01-15 The General Hospital Corporation Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein

Also Published As

Publication number Publication date
EP1100946A1 (en) 2001-05-23
WO2000005394A1 (en) 2000-02-03
JP2003527816A (en) 2003-09-24

Similar Documents

Publication Publication Date Title
AU7476800A (en) Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
AU2822195A (en) Mutant dwarfism gene of petunia
AU3882997A (en) Human telomerase gene
AU5134599A (en) Expression of functional eukaryotic proteins
AU2445601A (en) Mammalian protein phosphatases
AU6229498A (en) Composition for gene introduction into cell
AUPP224298A0 (en) Improved manner of electrical connection
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU4397797A (en) Method of gene introduction
AU4916299A (en) Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates
AU7126798A (en) Bipolar electrochemical connection of materials
AU2408397A (en) Ob protein receptor genes and use of the same
AU4320499A (en) Angiopoietin related gene sequence scarface 1
AU6659998A (en) Tazarotene-induced gene 3 (tig3)
AU5102799A (en) Multiple splice variants of the mu-opioid receptor gene
AU2058401A (en) Nucleic acids and polypeptides of invertebrate receptors and methods of use
AU6909700A (en) Gene transfer imaging and uses thereof
AU9380898A (en) Mammalian circadian rhythm-like gene
AU4227799A (en) Angiopoietin related gene sequence scarface 3
AU6580598A (en) (noey2) gene compositions and methods of use
AU5052999A (en) Human ccr-2 gene polymorphisms
AU9249098A (en) Use of universal culture medium ftir spectrometry
AU5590999A (en) Peptide scaffolds for transfer of molecules into eukaryotic cells
AUPP438598A0 (en) NPY-Y7 receptor gene
AUPP058797A0 (en) Novel gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase